News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Welcome to NFMart: The Future of NFT Marketplaces
NFMart Blog·2024/07/22 07:21

MIGGLES: The next meme star on the Base chain?
远山洞见·2024/07/22 06:06

NFMart (NFM): Simplifying NFT Market Creation with Generative AI
远山洞见·2024/07/20 04:00

CLOUD: The Sanctum Governance Token
Sanctum Blog·2024/07/19 07:15

CLOUD: The Sanctum Governance Token
Cloud Blog·2024/07/19 07:02

Sanctum (CLOUD) Investment Analysis: Project Analysis and Market Expectations
远山洞见·2024/07/18 18:21

Fully understand zkLink (ZKL): the solution to unify the multi-chain world
远山洞见·2024/07/18 18:20

Exploring Omax Coin (OMAX): A Layer-1 Blockchain Based on PoS
远山洞见·2024/07/17 08:26

Bitget Research: Bitcoin Continues to Rise Breaking $66,000, Memecoin Sector Demonstrates Significant Wealth Creation Effect
In the past 24 hours, many new popular tokens and topics have emerged in the market, which are likely to be the next wealth creation opportunities.
Bitget Research·2024/07/17 07:21
Flash
12:37
Institution: Lengthy tanker voyages mean oil market easing will be delayedGolden Ten Data reported on June 17 that a Rabobank energy strategist stated that even after the Strait of Hormuz reopens, the sailing time from the Persian Gulf to major Asian importing countries and the redeployment of oil tankers remain key constraints on how quickly the oil market can rebalance. A fully loaded oil tanker typically takes about 28 to 55 days to reach destinations such as India, China, South Korea, or Japan, which means that even if supply resumes, inventories will continue to be depleted. Strategists Joe DeLaura and Florence Schmit stated that, meanwhile, shipping companies operating tankers rerouted around the Cape of Good Hope to reach the Atlantic basin estimate that after any hostilities pause, it will still take one to two months for operations to fully restart.
12:35
Syscoin Releases Bridge Security Incident Report: Recovered Funds Have Been Burned and Cross-Layer Parsing Vulnerability Will Be FixedOdaily reported that Syscoin released a bridge security incident report, revealing details of the UTXO-to-NEVM bridge vulnerability. It is reported that this incident caused approximately 5 billion SYS to be unauthorizedly released on the UTXO side. The relevant funds have since been returned to the official recovery address and destroyed using the standard OP_RETURN method, making them unusable by the protocol again. The reported SYS supply on-chain has been restored to the expected value. Currently, bridging functionality remains suspended, as the team is completing final reviews and fixes. Syscoin stated that it will fix cross-layer parsing flaws, noting that the core lesson of this incident is that cross-layer systems must handle data in a standardized and unified manner, and any ambiguous bridge proofs should be considered failures by default.
12:34
AngioDynamics announced that its Relief feasibility study, which aims to evaluate the Nanoknife irreversible electroporation (IRE) platform as a minimally invasive treatment option for benign prostatic hyperplasia (BPH), has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA).This approval marks a critical step for the company in expanding the application of its innovative technology. The Nanoknife IRE platform is designed to ablate targeted tissue with precision electric field energy while maximizing the protection of surrounding healthy structures. The Relief study for BPH will evaluate the safety and preliminary efficacy of this platform as a potential minimally invasive treatment option.Benign prostatic hyperplasia is a common, age-related male urinary system condition that can result in lower urinary tract symptoms, significantly affecting patients’ quality of life. Current standard treatments include medication and more invasive surgical procedures. If the study results are positive, Nanoknife IRE technology may offer patients a new treatment option that could be less traumatic.Obtaining IDE approval enables AngioDynamics to initiate patient recruitment for this clinical study in the United States. The study’s progress will be closely watched by the medical community and investors, as it may open new market opportunities for the company and validate the potential application of its technology platform in the urology field.
News